Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Opko Health Inc (OPK)

Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies GlobeNewswire - Tue May 12, 7:00AM CDT

Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic B-cell depletion in animal models  Data will be presented at the American Society of Gene & Cell...

OPK : 1.3850 (-1.07%)
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China GlobeNewswire - Thu Apr 30, 7:30AM CDT

MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) today announced that its subsidiary EirGen Pharma Limited (EirGen) has entered into an amendment to its agreement with...

OPK : 1.3850 (-1.07%)
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform GlobeNewswire - Thu Apr 30, 7:00AM CDT

ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- BioReference® Health LLC, an OPKO Health, Inc. company and a trusted provider of diagnostic testing in the United States, today announced the launch...

OPK : 1.3850 (-1.07%)
OPKO Health: Q1 Earnings Snapshot AP - Tue Apr 28, 3:48PM CDT

OPKO Health: Q1 Earnings Snapshot

OPK : 1.3850 (-1.07%)
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results GlobeNewswire - Tue Apr 28, 3:05PM CDT

MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the...

OPK : 1.3850 (-1.07%)
OPKO Health's Diagnostics Dependency Meets Growing Questions About Lab Volume Trajectory Barchart - Mon Apr 27, 4:08PM CDT

Barchart Research What to Expect from OPK Earnings OPK Generated April 27, 2026 Current Price $1.2000 EPS Estimate $$-0.07 Consensus Rating Moderate Buy Average Move 4.81% OPKO Health's Diagnostics Dependency...

OPK : 1.3850 (-1.07%)
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas GlobeNewswire - Wed Apr 22, 7:00AM CDT

Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize killing of lymphomas Preclinical studies presented at 2025 American Society of Hematology...

OPK : 1.3850 (-1.07%)
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026 GlobeNewswire - Tue Apr 21, 3:05PM CDT

MIAMI, April 21, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2026 after the close of the U.S. financial...

OPK : 1.3850 (-1.07%)
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19 GlobeNewswire - Wed Apr 8, 7:00AM CDT

WESTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that the first participants have been dosed in a Phase 1 clinical trial...

OPK : 1.3850 (-1.07%)
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit GlobeNewswire - Fri Feb 27, 7:00AM CST

MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11,...

OPK : 1.3850 (-1.07%)

Barchart Exclusives

Dell Is the General Contractor of the Next Wave of the AI Buildout. DELL Stock Is Set to Win. Barchart - 1 minute ago
Dell's phenomenal Q1 earnings report reveals a tectonic shift in the AI market. As the ultimate "general contractor" of the new AI buildout wave, Dell is positioned to capitalize on infrastructure spending beyond Big Tech. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.